• 659 Citations
  • 16 h-Index
20082020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where James C.M. Brust is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
South Africa Medicine & Life Sciences
HIV Medicine & Life Sciences
Extensively Drug-Resistant Tuberculosis Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
tuberculosis Agriculture & Biology
Therapeutics Medicine & Life Sciences
Linezolid Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2010 2020

bedaquiline
Extensively Drug-Resistant Tuberculosis
Pharmacokinetics
HIV
Safety
South Africa
HIV
Therapeutics
Research
Research Personnel

Publications 2008 2019

  • 659 Citations
  • 16 h-Index
  • 34 Article
  • 3 Review article
  • 1 Chapter
  • 1 Letter
1 Citation (Scopus)

Linezolid pharmacokinetics in South African patients with drug-resistant tuberculosis and a high prevalence of HIV coinfection

Wasserman, S., Denti, P., Brust, J. C. M., Abdelwahab, M., Hlungulu, S., Wiesner, L., Norman, J., Sirgel, F. A., Warren, R. M., Esmail, A., Dheda, K., Gandhi, N. R., Meintjes, G. & Maartens, G., Mar 1 2019, In : Antimicrobial Agents and Chemotherapy. e02164-18.

Research output: Contribution to journalArticle

Linezolid
Multidrug-Resistant Tuberculosis
Coinfection
Pharmacokinetics
HIV

Management of active tuberculosis in adults with HIV

Meintjes, G., Brust, J. C. M., Nuttall, J. & Maartens, G., Jul 1 2019, In : The Lancet HIV. 6, 7, p. e463-e474

Research output: Contribution to journalReview article

Tuberculosis
HIV
Immune Reconstitution Inflammatory Syndrome
Drug Interactions
Pharmaceutical Preparations

RpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective analysis of prevalence, phenotypic, genotypic, and treatment outcomes

Mvelase, N. R., Pillay, M., Sibanda, W., Ngozo, J. N., Brust, J. C. M. & Mlisana, K. P., Apr 1 2019, In : Open Forum Infectious Diseases. 6, 4, ofz065.

Research output: Contribution to journalArticle

Open Access
Rifampin
Mycobacterium tuberculosis
Rifabutin
Multidrug-Resistant Tuberculosis
Mutation
2 Citations (Scopus)

A new era for treatment of drug-resistant tuberculosis

Gandhi, N. R., Brust, J. C. M. & Sarita Shah, N., Oct 1 2018, In : European Respiratory Journal. 52, 4

Research output: Contribution to journalReview article

Open Access
Multidrug-Resistant Tuberculosis
3 Citations (Scopus)

Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities

Auld, S. C., Shah, N. S., Mathema, B., Brown, T. S., Ismail, N., Omar, S. V., Brust, J. C. M., Nelson, K. N., Allana, S., Campbell, A., Mlisana, K., Moodley, P. & Gandhi, N. R., Oct 1 2018, In : The European respiratory journal. 52, 4

Research output: Contribution to journalArticle

Extensively Drug-Resistant Tuberculosis
Single Nucleotide Polymorphism
South Africa
Mycobacterium tuberculosis
Genome